IRIS
VITA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.356
NA - Nord America 5.336
AS - Asia 4.251
SA - Sud America 1.366
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 18.463
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.206
RU - Federazione Russa 3.823
SG - Singapore 1.951
BR - Brasile 1.170
CN - Cina 1.138
IE - Irlanda 902
SE - Svezia 602
IT - Italia 551
HK - Hong Kong 384
PL - Polonia 333
DE - Germania 288
FR - Francia 282
VN - Vietnam 280
FI - Finlandia 178
GB - Regno Unito 159
IN - India 128
UA - Ucraina 81
AR - Argentina 76
MX - Messico 55
BD - Bangladesh 50
CA - Canada 49
TR - Turchia 45
IQ - Iraq 43
ZA - Sudafrica 38
ID - Indonesia 36
BE - Belgio 32
AT - Austria 30
EC - Ecuador 30
CI - Costa d'Avorio 28
JP - Giappone 28
NL - Olanda 23
VE - Venezuela 22
PK - Pakistan 21
CO - Colombia 20
MA - Marocco 19
CL - Cile 16
ES - Italia 15
KE - Kenya 15
UZ - Uzbekistan 15
LT - Lituania 13
MY - Malesia 13
PH - Filippine 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 10
JO - Giordania 10
PE - Perù 10
PY - Paraguay 10
TN - Tunisia 10
EU - Europa 9
AZ - Azerbaigian 8
IL - Israele 8
KZ - Kazakistan 8
NP - Nepal 8
AU - Australia 7
CR - Costa Rica 7
EG - Egitto 7
UY - Uruguay 6
DO - Repubblica Dominicana 5
OM - Oman 5
RO - Romania 5
JM - Giamaica 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
GY - Guiana 3
HU - Ungheria 3
IR - Iran 3
KR - Corea 3
LB - Libano 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
GA - Gabon 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
Totale 18.442
Salva come PNG Salva come JPEG
Città #
Moscow 1.121
Dublin 901
Ashburn 869
Singapore 811
Chandler 615
Dallas 585
Beijing 424
Hong Kong 384
Nyköping 377
Warsaw 321
Jacksonville 236
The Dalles 220
San Jose 182
Princeton 175
Messina 146
Medford 140
Lauterbourg 137
Ann Arbor 135
Los Angeles 124
Cambridge 114
Ho Chi Minh City 100
Munich 92
Des Moines 91
New York 88
São Paulo 81
Boardman 63
Buffalo 62
Dearborn 62
Lancaster 59
Bremen 58
Tianjin 58
Shenyang 57
Pune 53
San Mateo 49
Council Bluffs 47
Turku 47
Frankfurt am Main 46
Orem 44
Hanoi 43
Jinan 42
Rio de Janeiro 42
Wilmington 42
Redondo Beach 41
Houston 36
Rome 34
Belo Horizonte 32
Brussels 30
Nanjing 30
Abidjan 28
Guangzhou 28
Tokyo 25
Chennai 24
Hebei 23
Porto Alegre 23
Brooklyn 22
Curitiba 22
Hangzhou 22
Helsinki 22
Ningbo 22
Brasília 21
Santa Clara 21
Zhengzhou 21
Dong Ket 20
Atlanta 19
Baghdad 19
Milan 19
Amsterdam 17
Toronto 17
London 16
Johannesburg 15
Montreal 15
Stockholm 15
Woodbridge 15
Jakarta 14
Nuremberg 14
Salvador 14
Seattle 14
Shanghai 14
Tashkent 14
Vienna 14
Catania 13
Changsha 13
Manchester 13
Palo Del Colle 13
Taizhou 13
Denver 12
Guarulhos 12
Mexico City 12
Nanchang 12
Quito 12
Chicago 11
Dhaka 11
Haikou 11
Hyderabad 11
Istanbul 11
Juiz de Fora 11
Nairobi 11
Norwalk 11
Poplar 11
Campinas 10
Totale 10.389
Salva come PNG Salva come JPEG
Nome #
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 326
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 284
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 255
Clinical and pathological features of focal myositis 248
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 245
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 216
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 205
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 197
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 194
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 193
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 193
Hippo signaling pathway is altered in Duchenne muscular dystrophy 186
Effect of exercise on telomere length and telomere proteins expression in mdx mice 186
Autonomic nervous system involvement in spinal muscular atrophy. 184
Nusinersen versus sham control in later-onset spinal muscular atrophy 182
ANT1 is reduced in sporadic inclusion body myositis. 175
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 173
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 173
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 173
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 168
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 168
Pilot study of flavocoxid in ambulant DMD patients. 167
Pilot study of serial casting in muscular dystrophy patients. 165
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 165
Pilot study of serial casting of ankles in muscular dystrophy patients. 164
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 164
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 163
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 158
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 156
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 152
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 152
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 152
The 24-month PUL changes and steroids correlation. 151
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 151
Pilot study of flavocoxid in ambulant DMD patients. 149
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 149
Emergenze respiratorie nelle malattie neurologiche 149
Pilot study of flavocoxid in ambulant DMD patients. 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 148
Psychosocial impact of sport activity in neuromuscular disorders 148
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 147
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 146
Severe rhabdomyolysis in a patient with “Heat Stroke” 146
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 146
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 143
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 143
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 143
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 139
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 139
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 139
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 139
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 138
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 138
Clinical variability in spinal muscular atrophy type III 138
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 136
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 136
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 135
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 134
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 134
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 134
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 133
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Amyloid myopathy presenting with rhabdomyolysis. 131
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 131
Practical approach to respiratory emergencies in neurological diseases 130
6 min walking test 12 month changes in DMD: Correlation with genotype. 129
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 129
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 128
Implication of SIRT1 and its downstream pathways in dystrophic process. 128
study of flavocoxid in ambulant DMD patients. 127
Bone quality in Duchenne muscular dystrophy 126
Histological effects of givinostat in boys with Duchenne muscular dystrophy 125
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 125
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 125
Dolori muscolari, deficit di forza e/o disturbi sensitivi 123
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 121
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 118
Pilot study of flavocoxid in ambulant DMD patients. 118
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 118
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 117
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys 115
Role of calcineurin/NFAT on muscle regeneration in dystrophic process. 114
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 114
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 113
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 113
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 112
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 110
Respiratory Emergencies in Neurological Diseases 110
Miopatia prossimale in paziente con sindrome di Williams 106
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 99
Pilot study of flavocoxid in ambulant DMD patients. 99
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 98
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 98
Telomere length in exercised wild type and mdx mice. 98
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 96
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 94
FSHD and Williams syndrome: the occurrence of two genetic disorders due to heterozygous DNA fragment deletions in the same patient. 93
Totale 14.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.745
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 80 36 38
2021/2022949 10 97 4 64 48 6 94 37 33 91 88 377
2022/20232.391 195 227 125 158 202 197 18 114 1.081 6 57 11
2023/2024724 31 114 35 82 52 174 35 41 5 32 25 98
2024/20253.384 61 45 39 190 91 84 76 640 721 188 537 712
2025/20268.854 471 615 701 677 724 1.858 1.112 1.122 1.202 372 0 0
Totale 18.830